CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 3, May/June 2011
AFRICA
121
cardiovascular disease prevention in women.
Circulation
2004;
109
:
672–693.
13. Mosca L, Banka CL, Benjamin EJ,
et al.
Evidence-based guidelines for
cardiovascular disease prevention in women: 2007 update.
Circulation
2007;
115
: 1481–1501.
14. Lakoski SG, Greenland P, Wong ND,
et al
. Coronary artery calcium
scores and risk for cardiovascular events in women classified as ‘low
risk’ based on Framingham risk score: the Multi-Ethnic Study of
Atherosclerosis (MESA).
Arch Intern Med
2007;
167
: 2437–2442.
15. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds
TP-III risk thresholds? Systematic examination of the effect of varying
age and risk factor levels in the ATP-III risk assessment tool.
Prev Med
2008;
47
: 619–623.
16. Vasan RS, Sullivan LM, Wilson PW,
et al
. Relative importance of
borderline and elevated levels of coronary heart disease risk factors.
Ann Intern Med
2005;
142
: 393–402.
17. Mosca L, Benjamin EJ , Berra K,
et al.
Effectiveness-based guidelines
for the prevention of cardiovascular disease in women – 2011 update:
A guideline from the American Heart Association.
Circulation
2011;
123
: 1243–1262.
18. D’Agostino RB Sr, Vasan RS, Pencina MJ,
et al
. General cardiovascu-
lar risk profile for use in primary care: the Framingham Heart Study.
Circulation
2008;
117
: 743–753.
19. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation
of improved algorithms for the assessment of global cardiovascular
risk in women: the Reynolds risk score.
J Am Med Assoc
2007; 297:
611–619.
20. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid
arthritis and systemic lupus erythematosus.
Am J Med
2008;
121
(suppl
1): S3–S8.
21. Bellamy L, Casas JP, Hingorani AD,
et al
. Pre-eclampsia and risk of
cardiovascular disease and cancer in later life: systematic review and
meta-analysis.
Br Med J
2007;
335
: 974.
22. Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging
risk factor for cardiovascular disease.
Nat Clin Pract Nephrol
2007;
3
: 613–622.
23. Hlatky MA, Greenland P, Arnett DK,
et al
. Criteria for evaluation of
novel markers of cardiovascular risk: a scientific statement from the
American Heart Association.
Circulation
2009;
119
: 2408–2416.
24. Greenland P, Alpert JS, Beller GA,
et al
. 2010 ACCF/AHA guideline
for assessment of cardiovascular risk in asymptomatic adults: a report
of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines.
Circulation
2010;
122
:
e584–e636.
25. Lloyd-Jones DM, Hong Y, Labarthe D,
et al.
Defining and setting
national goals for cardiovascular health promotion and disease reduc-
tion: the American Heart Association’s Strategic Impact Goal through
2020 and beyond.
Circulation
2010;
121
: 586–613.
